{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:11:00Z","timestamp":1758708660248},"reference-count":19,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":118,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharmacology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1002\/jcph.498","type":"journal-article","created":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T21:16:07Z","timestamp":1427231767000},"page":"920-925","source":"Crossref","is-referenced-by-count":3,"title":["Imatinib-induced agranulocytosis in patients with gastrointestinal stromal tumors"],"prefix":"10.1002","volume":"55","author":[{"given":"Sheima","family":"Farag","sequence":"first","affiliation":[{"name":"Netherlands Cancer Institute\/Antoni van Leeuwenhoek Hospital; Department of Medical Oncology; Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjan J.","family":"Verschoor","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center; Department of Clinical Oncology; Leiden the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob W.","family":"Bosma","sequence":"additional","affiliation":[{"name":"Netherlands Cancer Institute\/Antoni van Leeuwenhoek Hospital; Department of Medical Oncology; Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Gelderblom","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center; Department of Clinical Oncology; Leiden the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Martijn","family":"Kerst","sequence":"additional","affiliation":[{"name":"Netherlands Cancer Institute\/Antoni van Leeuwenhoek Hospital; Department of Medical Oncology; Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Sleijfer","sequence":"additional","affiliation":[{"name":"Erasmus MC - Cancer Institute; Department of Medical Oncology; Rotterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neeltje","family":"Steeghs","sequence":"additional","affiliation":[{"name":"Netherlands Cancer Institute\/Antoni van Leeuwenhoek Hospital; Department of Medical Oncology; Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,5,6]]},"reference":[{"issue":"1)","key":"10.1002\/jcph.498-BIB0001|jcph498-cit-0001","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0037-1963(03)70042-0","article-title":"Imatinib alone and in combination for chronic myeloid leukemia","volume":"40","author":"Druker","year":"2003","journal-title":"Semin Hematol."},{"issue":"7)","key":"10.1002\/jcph.498-BIB0002|jcph498-cit-0002","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors","volume":"347","author":"Demetri","year":"2002","journal-title":"N Engl J Med."},{"issue":"9)","key":"10.1002\/jcph.498-BIB0003|jcph498-cit-0003","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","article-title":"Systematic review: agranulocytosis induced by nonchemotherapy drugs","volume":"146","author":"Andersohn","year":"2007","journal-title":"Ann Intern Med."},{"issue":"2)","key":"10.1002\/jcph.498-BIB0004|jcph498-cit-0004","first-page":"144","article-title":"Malignant gastrointestinal stromal tumor of the small intestine complicated with pulmonary tuberculosis during treatment with imatinib mesylate","volume":"44","author":"Takashima","year":"2005","journal-title":"Int Med."},{"issue":"4","key":"10.1002\/jcph.498-BIB0005|jcph498-cit-0005","first-page":"320","article-title":"Imatinib-induced agranulocytosis in a patient with chronic myelogenous leukemia in remission","volume":"10","author":"Khouri","year":"2008","journal-title":"Isr Med Assoc J"},{"key":"10.1002\/jcph.498-BIB0006|jcph498-cit-0006","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1634\/stemcells.2005-0069","article-title":"Effects of imatinib in normal hematopoiesis and immune activation","volume":"23","author":"Appel","year":"2005","journal-title":"Stem Cells."},{"issue":"9440)","key":"10.1002\/jcph.498-BIB0007|jcph498-cit-0007","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0140-6736(04)17098-0","article-title":"Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial","volume":"364","author":"Verweij","year":"2004","journal-title":"Lancet."},{"issue":"14)","key":"10.1002\/jcph.498-BIB0008|jcph498-cit-0008","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.ejca.2006.03.029","article-title":"Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib: a study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Trials Group (EORTC-ISG-AGITG)","volume":"42","author":"Van Glabbeke","year":"2006","journal-title":"Eur J Cancer."},{"issue":"9)","key":"10.1002\/jcph.498-BIB0009|jcph498-cit-0009","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMoa011573","article-title":"Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia","volume":"346","author":"Kantarjian","year":"2002","journal-title":"N Engl J Med."},{"key":"10.1002\/jcph.498-BIB0010|jcph498-cit-0010","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/10428199809057558","article-title":"Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis","author":"Escribano","year":"1998","journal-title":"Leuk Lymphoma."},{"issue":"2)","key":"10.1002\/jcph.498-BIB0011|jcph498-cit-0011","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1182\/blood-2003-05-1535","article-title":"Inhibitory effect of imatinib on normal progenitor cells in vitro","volume":"103","author":"Bartolovic","year":"2004","journal-title":"Blood."},{"issue":"3)","key":"10.1002\/jcph.498-BIB0012|jcph498-cit-0012","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2141.2002.03500.x","article-title":"Platelet-derived growth factor promotes ex vivo expansion of CD34+ cells from human cord blood and enhances long-term culture-initiating cells, non-obese diabetic\/severe combined immunodeficient repopulating cells and formation of adherent cells","volume":"117","author":"Su","year":"2002","journal-title":"Br J Haematol."},{"key":"10.1002\/jcph.498-BIB0013|jcph498-cit-0013","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/1471-2407-10-438","article-title":"Imatinib induced severe skin reactions and neutropenia in a patient with gastrointestinal stromal tumor","volume":"10","author":"Hwang","year":"2010","journal-title":"BMC Cancer."},{"issue":"5)","key":"10.1002\/jcph.498-BIB0014|jcph498-cit-0014","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0953-6205(02)00085-7","article-title":"Modern management of non-chemotherapy drug-induced agranulocytosis: a monocentric cohort study of 90 cases and review of the literature","volume":"13","author":"Andr\u00e8s","year":"2002","journal-title":"Eur J Intern Med."},{"issue":"12)","key":"10.1002\/jcph.498-BIB0015|jcph498-cit-0015","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1002\/cncr.20285","article-title":"Granulocyte-colony-stimulating factor (filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase chronic myelogenous leukemia","volume":"100","author":"Quintas-Cardama","year":"2004","journal-title":"Cancer."},{"key":"10.1002\/jcph.498-BIB0016|jcph498-cit-0016","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.leu.2402869","article-title":"G-CSF for Imatinib-induced neutropenia","volume":"17","author":"Heim","year":"2003","journal-title":"Leukemia."},{"key":"10.1002\/jcph.498-BIB0017|jcph498-cit-0017","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/ajh.21383","article-title":"Persistent neutropenia in chronic meylogenous leukemia in chronic phase treated with imatinib mesylate","volume":"84","author":"Hwang","year":"2009","journal-title":"Am J of Hematol."},{"key":"10.1002\/jcph.498-BIB0018|jcph498-cit-0018","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1365-2257.2006.00772.x","article-title":"Imatinib-associated neutropenia may not be overcome by filgrastim treatment in patients with blastic phase of chronic myeloid leukaemia","volume":"28","author":"Zaucha","year":"2006","journal-title":"Clin Lab Haem."},{"key":"10.1002\/jcph.498-BIB0019|jcph498-cit-0019","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s12185-011-0887-7","article-title":"Berbamine overcomes imatinib-induced neutropenia and permits cytogenic responses in Chinese patients with chronic-phase chronic myeloid leukemia","volume":"94","author":"Zhao","year":"2011","journal-title":"Int J. Hematol."}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcph.498","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jcph.498","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T13:04:26Z","timestamp":1657803866000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcph.498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,6]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"URL":"https:\/\/doi.org\/10.1002\/jcph.498","relation":{},"ISSN":["0091-2700"],"issn-type":[{"value":"0091-2700","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5,6]]}}}